Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats

• Published in: Journal of pharmacy and pharmacology Vol. 72; no. 3; p. 448
• Main Authors: Zhang, Jiaxin, Xie, Qiushi, Kong, Weimin, Wang, Zhongjian, Wang, Shuting, Zhao, Kaijing, Chen, Yang, Liu, Xiaodong, Liu, Li
• Format: Journal Article
• Language: English
• Published: England 01.03.2020
• Subjects: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism; Cytochrome P-450 CYP3A - metabolism; Fatty Acids, Volatile - metabolism; Fatty Acids, Volatile - pharmacology; Male; Rats; Rats, Sprague-Dawley; Verapamil - pharmacokinetics; P-glycoprotein; cytochrome P4503A; pharmacokinetics; short-chain fatty acids; verapamil
• ISSN: 2042-7158
• DOI: 10.1111/jphp.13215

To investigate effects of short-chain fatty acids (SCFAs) on expressions and functions of intestinal cytochrome P4503A (Cyp3a) and P-glycoprotein (P-gp). To develop a semi-physiologically based pharmacokinetic (semi-PBPK) model for assessing their contributions. Verapamil pharmacokinetics was investigated following oral administration to rats receiving water containing 150 mm SCFAs for 3 weeks. Cyp3a activities in intestinal and liver mircosomes were assessed by norverapamil formation. In-situ single-pass perfusion was used to evaluate intestinal transport of verapamil and P-gp function. Functions and expressions of Cyp3a and P-gp were measured in mouse primary enterocytes following 48-h exposure to SCFAs. Contributions of intestinal P-gp and Cyp3a to verapamil pharmacokinetics were assessed using a semi-PBPK model. Short-chain fatty acids significantly increased oral plasma exposures of verapamil and norverapamil. SCFAs upregulated Cyp3a activity and expression, but downregulated P-gp function and expression in rat intestine, which were repeated in mouse primary enterocytes. PBPK simulation demonstrated contribution of intestinal Cyp3a to oral plasma verapamil exposure was minor, and the increased oral plasma verapamil exposure was mainly attributed to downregulation of intestinal P-gp. Short-chain fatty acids oppositely regulated functions and expressions of intestinal Cyp3a and P-gp. The downregulation of P-gp mainly contributed to the increased oral plasma verapamil exposure by SCFAs.